{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:00:40Z","timestamp":1791928840459,"version":"4.3.4"},"reference-count":51,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"4","license":[{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2024,4,23]]},"DOI":"10.1167\/iovs.65.4.37","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T12:30:49Z","timestamp":1716294649000},"page":"37","source":"Crossref","is-referenced-by-count":12,"title":["Short Term Effect of Pre-Operative Anti-VEGF on Angiogenic and Fibrotic Profile of Fibrovascular Membranes of Proliferative Diabetic Retinopathy"],"prefix":"10.1167","volume":"65","author":[{"given":"Kaveh","family":"Fadakar","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States"},{"name":"Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Rahmani","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tedeschi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy A.","family":"Lavine","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani A.","family":"Fawzi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"3","key":"bib1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"issue":"1","key":"bib2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/(ISSN)1099-0895","article-title":"Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy","volume":"13","author":"Miller","year":"1997","journal-title":"Diabetes Metab Rev"},{"issue":"2","key":"bib3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.preteyeres.2007.12.002","article-title":"Fibrotic disorders in the eye: targets of gene therapy","volume":"27","author":"Saika","year":"2008","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"bib4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.exer.2006.01.016","article-title":"Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors","volume":"83","author":"Arjamaa","year":"2006","journal-title":"Exp Eye Res"},{"issue":"12","key":"bib5","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1136\/bjo.2006.098426","article-title":"Vascular endothelial growth factor biology: clinical implications for ocular treatments","volume":"90","author":"Bhisitkul","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"bib6","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00417-008-0774-y","article-title":"Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR)","volume":"246","author":"Rizzo","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"bib7","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.survophthal.2021.03.001","article-title":"Anti-VEGF crunch syndrome in proliferative diabetic retinopathy: a review","volume":"66","author":"Tan","year":"2021","journal-title":"Surv Ophthalmol"},{"issue":"7","key":"bib8","doi-asserted-by":"publisher","first-page":"e2675","DOI":"10.1371\/journal.pone.0002675","article-title":"The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy","volume":"3","author":"Kuiper","year":"2008","journal-title":"PLoS One"},{"issue":"9","key":"bib9","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1001\/archophthalmol.2012.1611","article-title":"Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1","volume":"130","author":"Sohn","year":"2012","journal-title":"Arch Ophthalmol (Chicago, Ill 1960)"},{"issue":"6","key":"bib10","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1007\/s00417-021-05515-3","article-title":"Comparison of before versus after intravitreal bevacizumab injection, growth factor levels and fibrotic markers in vitreous samples from patients with proliferative diabetic retinopathy","volume":"260","author":"Ozer","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"bib11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1167\/tvst.9.6.16","article-title":"microRNA expression profile in the vitreous of proliferative diabetic retinopathy patients and differences from patients treated with anti-VEGF therapy","volume":"9","author":"Friedrich","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"13","key":"bib12","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.1167\/iovs.17-22345","article-title":"Vitreous fibronectin and fibrinogen expression increased in eyes with proliferative diabetic retinopathy after intravitreal anti-VEGF therapy","volume":"58","author":"Wei","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"bib13","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.ophtha.2008.12.024","article-title":"Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy","volume":"116","author":"Arimura","year":"2009","journal-title":"Ophthalmology"},{"issue":"5","key":"bib14","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1167\/iovs.09-4065","article-title":"Alterations in the intraocular cytokine milieu after intravitreal bevacizumab","volume":"51","author":"Forooghian","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"bib15","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1136\/bjophthalmol-2015-308199","article-title":"The relationship between anti-vascular endothelial growth factor and fibrosis in proliferative retinopathy: clinical and laboratory evidence","volume":"100","author":"Zhang","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"bib16","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/IAE.0b013e3182753b41","article-title":"Altered vascular microenvironment by bevacizumab in diabetic fibrovascular membrane","volume":"33","author":"Nakao","year":"2013","journal-title":"Retina"},{"issue":"4","key":"bib17","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.ophtha.2010.08.038","article-title":"Preoperative intravitreal bevacizumab use as an adjuvant to diabetic vitrectomy: histopathologic findings and clinical implications","volume":"118","author":"El-Sabagh","year":"2011","journal-title":"Ophthalmology"},{"issue":"2","key":"bib18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ajo.2010.03.016","article-title":"Histopathology of neovascular tissue from eyes with proliferative diabetic retinopathy after intravitreal bevacizumab injection","volume":"150","author":"Kohno","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"bib19","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1097\/IAE.0b013e3181cb463a","article-title":"Fibrous membranes in diabetic retinopathy and bevacizumab","volume":"30","author":"Pattwell","year":"2010","journal-title":"Retina"},{"issue":"2","key":"bib20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/IAE.0000000000001952","article-title":"Apoptosis and angiofibrosis in diabetic tractional membranes after vascular endothelial growth factor inhibition: results of a Prospective Trial. Report No. 2","volume":"39","author":"Jiao","year":"2019","journal-title":"Retina"},{"issue":"4","key":"bib21","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin Chem"},{"issue":"2","key":"bib22","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1167\/iovs.14-15589","article-title":"Microarray analysis of gene expression in fibrovascular membranes excised from patients with proliferative diabetic retinopathy","volume":"56","author":"Ishikawa","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"45","key":"bib23","doi-asserted-by":"publisher","first-page":"17504","DOI":"10.1073\/pnas.0804054105","article-title":"Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target","volume":"105","author":"Kita","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"bib24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2337\/db06-0581","article-title":"Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor","volume":"56","author":"Kita","year":"2007","journal-title":"Diabetes"},{"issue":"4","key":"bib25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/bjophthalmol-2011-301005","article-title":"A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy","volume":"96","author":"Van Geest","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"bib26","article-title":"Single cell transcriptomic analysis of proliferative diabetic retinopathy fibrovascular membranes reveals AEBP1 as fibrogenesis modulator","author":"Corano-Scheri","journal-title":"JCI Insight"},{"issue":"2","key":"bib27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/ATVBAHA.107.158014","article-title":"VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation","volume":"28","author":"Vestweber","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"bib28","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.exer.2010.08.008","article-title":"Attenuation of streptozotocin-induced microvascular changes in the mouse retina with the endothelin receptor A antagonist atrasentan","volume":"91","author":"Wang","year":"2010","journal-title":"Exp Eye Res"},{"issue":"10","key":"bib29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/tvst.11.10.5","article-title":"Hemodynamic effects of anti-vascular endothelial growth factor injections on optical coherence tomography angiography in diabetic macular edema eyes","volume":"11","author":"Song","year":"2022","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"bib30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1161\/HYPERTENSIONAHA.111.173559","article-title":"The vascular endothelial growth factor receptor inhibitor sunitinib causes a preeclampsia-like syndrome with activation of the endothelin system","volume":"58","author":"Kappers","year":"2011","journal-title":"Hypertens (Dallas, Tex 1979)"},{"issue":"4","key":"bib31","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1161\/HYPERTENSIONAHA.109.149690","article-title":"Hypertension induced by the tyrosine kinase inhibitor sunitinib is associated with increased circulating endothelin-1 levels","volume":"56","author":"Kappers","year":"2010","journal-title":"Hypertens (Dallas, Tex 1979)"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"8381115","DOI":"10.1155\/2021\/8381115","article-title":"Bevacizumab increases endothelin-1 production via Forkhead box protein O1 in human glomerular microvascular endothelial cells in vitro","volume":"2021","author":"Nihei","year":"2021","journal-title":"Int J Nephrol"},{"issue":"10","key":"bib33","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrm.2016.87","article-title":"Mechanisms and regulation of endothelial VEGF receptor signalling","volume":"17","author":"Simons","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"bib34","doi-asserted-by":"publisher","first-page":"1695.e1","DOI":"10.1016\/j.ophtha.2006.05.064","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"issue":"9","key":"bib35","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1097\/01.iae.0000246884.76018.63","article-title":"Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study)","volume":"26","author":"Jorge","year":"2006","journal-title":"Retina"},{"issue":"3","key":"bib36","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/IAE.0b013e3181bd2d7b","article-title":"Histology of fibrovascular membranes of proliferative diabetic retinopathy after intravitreal injection of bevacizumab","volume":"30","author":"Kubota","year":"2010","journal-title":"Retina"},{"key":"bib37","first-page":"1","article-title":"Effects of bevacizumab on the neovascular membrane of proliferative diabetic retinopathy: reduction of endothelial cells and expressions of VEGF and HIF-1a","volume":"18","author":"Han","year":"2012","journal-title":"Mol Vis"},{"issue":"4","key":"bib38","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.cell.2007.06.054","article-title":"Autocrine VEGF signaling is required for vascular homeostasis","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"issue":"2","key":"bib39","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bbrc.2015.11.108","article-title":"Expression of angiopoietin-1 in hypoxic pericytes: regulation by hypoxia-inducible factor-2a and participation in endothelial cell migration and tube formation","volume":"469","author":"Park","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00441-003-0749-6","article-title":"Role of angiopoietins and tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis","volume":"314","author":"Thurston","year":"2003","journal-title":"Cell Tissue Res"},{"issue":"1","key":"bib41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/01.RES.86.1.24","article-title":"Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-kinase\/Akt signal transduction pathway","volume":"86","author":"Kim","year":"2000","journal-title":"Circ Res"},{"issue":"5","key":"bib42","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ccr.2004.09.030","article-title":"Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2","volume":"6","author":"Oliner","year":"2004","journal-title":"Cancer Cell"},{"issue":"22","key":"bib43","doi-asserted-by":"publisher","first-page":"15732","DOI":"10.1074\/jbc.274.22.15732","article-title":"Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells","volume":"274","author":"Oh","year":"1999","journal-title":"J Biol Chem"},{"issue":"8","key":"bib44","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1161\/01.RES.83.8.852","article-title":"Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia","volume":"83","author":"Mandriota","year":"1998","journal-title":"Circ Res"},{"issue":"5322","key":"bib45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"issue":"5422","key":"bib46","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1126\/science.284.5422.1994","article-title":"Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF","volume":"284","author":"Holash","year":"1999","journal-title":"Science"},{"issue":"17","key":"bib47","doi-asserted-by":"publisher","first-page":"11205","DOI":"10.1073\/pnas.172161899","article-title":"Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo","volume":"99","author":"Lobov","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14","key":"bib48","first-page":"2006","article-title":"Intrinsic versus microenvironmental regulation of lymphatic endothelial cell phenotype and function","volume":"17","author":"Veikkola","year":"2003","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"issue":"4","key":"bib49","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.celrep.2013.07.021","article-title":"The calcineurin-NFAT-angiopoietin-2 signaling axis in lung endothelium is critical for the establishment of lung metastases","volume":"4","author":"Minami","year":"2013","journal-title":"Cell Rep"},{"issue":"13","key":"bib50","doi-asserted-by":"publisher","first-page":"12171","DOI":"10.1074\/jbc.M305146200","article-title":"Hypoxic regulation of angiopoietin-2 expression in endothelial cells","volume":"279","author":"Pichiule","year":"2004","journal-title":"J Biol Chem"},{"issue":"14","key":"bib51","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1158\/1078-0432.CCR-09-3073","article-title":"Angiopoietin-2 interferes with anti-VEGFR2-induced vessel normalization and survival benefit in mice bearing gliomas","volume":"16","author":"Chae","year":"2010","journal-title":"Clin Cancer Res"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2793600","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:53Z","timestamp":1791927113000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2793600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.65.4.37","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,23]]}}}